-
1621por Hamada, T, Nakai, Y, Yasunaga, H, Isayama, H, Matsui, H, Takahara, N, Sasaki, T, Takagi, K, Watanabe, T, Yagioka, H, Kogure, H, Arizumi, T, Yamamoto, N, Ito, Y, Hirano, K, Tsujino, T, Tada, M, Koike, K“…A nomogram to predict survival in nonresectable pancreatic cancer treated with chemotherapy has not been reported. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1622por Nie, Song, Lo, Andy, Wu, Jing, Zhu, Jianhui, Tan, Zhijing, Simeone, Diane M., Anderson, Michelle A., Shedden, Kerby A., Ruffin, Mack T., Lubman, David M.“…[Image: see text] Pancreatic cancer is a lethal disease where specific early detection biomarkers would be very valuable to improve outcomes in patients. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1623por Han, Suxia, Jin, Guihua, Wang, Lijuan, Li, Meng, He, Chenchen, Guo, Xijing, Zhu, Qing“…PAM4, a new monoclonal antibody (MAb) known as clivatuzumab, is highly reactive with pancreatic cancer and precursor lesions. It is absent from the normal tissues and has limited reactivity with nonpancreatic cancer. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1624por Morris, John P., Greer, Renee, Russ, Holger A., von Figura, Guido, Kim, Grace E., Busch, Anke, Lee, Jonghyeob, Hertel, Klemens J., Kim, Seung, Mcmanus, Michael, Hebrok, MatthiasEnlace del recurso
Publicado 2014
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1625“…BACKGROUND: The purpose of this meta-analysis is to compare the efficacy of pancreatoduodenectomy (PD) with extended lymphadenectomy (PD/ELND) versus standard PD in the treatment of pancreatic cancer, with the hope of providing evidence for clinical practice. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1626por Sun, Hongwei, Lv, Chongqing, Yang, Longlong, Wang, Yingxiu, Zhang, Qingshun, Yu, Suhui, Kong, Hongru, Wang, Meng, Xie, Jianming, Zhang, Chunwu, Zhou, Mengtao“…Here, we reported that solanine, a substance of steroid alkaloids, has a positive effect on the inhibition of pancreatic cancer cell growth in vitro and in vivo. In pancreatic cancer cells and nu/nu nude mice model, we found that solanine inhibited cancer cells growth through caspase-3 dependent mitochondrial apoptosis. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1627por Tan, Xiao-ping, Dong, Wei-guo, Zhang, Qing, Yang, Zi-rong, Lei, Xiao-fei, Ai, Ming-hua“…In conclusion, increased expression of Mina53 may play an important role in the development of human pancreatic cancer. Mina53 can be used as a marker for pancreatic cancer and may potentially be exploited as a target for treatment of pancreatic cancer.…”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1628por Pekala, Kelly R., Ma, Xidi, Kropp, Peter A., Petersen, Christine P., Hudgens, Courtney W., Chung, Christine H., Shi, Chanjuan, Merchant, Nipun, Maitra, Anirban, Means, Anna L., Gannon, Maureen“…Insight on the role of HNF6 in pancreatic cancer development could lead to its use as a biomarker for early detection and prognosis.…”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1629por Lyssiotis, Costas, Son, Jaekyoung, Mancias, Joesph, Ying, Haoqiang, Kimmelman, Alec, Cantley, LewisEnlace del recurso
Publicado 2014
Enlace del recurso
Online Artículo Texto -
1630“…Objective: This retrospective study compared the advantages and disadvantages of iodine-125 (125I) seed implantation and pancreaticoduodenectomy (PD) in the treatment of pancreatic cancer. Methods: Patients with diagnosed pancreatic cancer who were treated with 125125I seed implantation (30 patients) or PD (30 patients) in our hospital were evaluated for operative time, bleeding, liver function, time to first bowel movement and normal diet, survival, and medical costs. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1631“…BACKGROUND: Diabetes is a risk factor for pancreatic cancer but its association with survival from pancreatic cancer is poorly understood. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1632“…The most glycolytic pancreatic cancer cell line was exquisitely sensitive to 2-DG, whereas the least glycolytic pancreatic cancer cell was resistant to 2-DG. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1633por Garajová, Ingrid, Le Large, Tessa Y., Frampton, Adam E., Rolfo, Christian, Voortman, Johannes, Giovannetti, ElisaEnlace del recurso
Publicado 2014
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1634por Oh, Tak Geun, Chung, Moon Jae, Bang, Seungmin, Park, Seung Woo, Chung, Jae Bok, Song, Si Young, Seong, Jinsil, Kang, Chang Moo, Lee, Woo Jung, Park, Jeong Youp“…BACKGROUND/AIMS: Among borderline resectable pancreatic cancer (BRPC), group B BRPC patients have findings that are suggestive but not diagnostic of metastasis. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1635por Shukla, Surendra K, Gebregiworgis, Teklab, Purohit, Vinee, Chaika, Nina V, Gunda, Venugopal, Radhakrishnan, Prakash, Mehla, Kamiya, Pipinos, Iraklis I, Powers, Robert, Yu, Fang, Singh, Pankaj K“…Ketone bodies also diminished glutamine uptake, overall ATP content, and survival in multiple pancreatic cancer cell lines, while inducing apoptosis. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1636por Wang, Jin, Raimondo, Massimo, Guha, Sushovan, Chen, Jinyun, Diao, Lixia, Dong, Xiaoqun, Wallace, Michael B., Killary, Ann M., Frazier, Marsha L., Woodward, Timothy A., Wang, Jing, Sen, SubrataEnlace del recurso
Publicado 2014
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1637por Alvarez, R, Musteanu, M, Garcia-Garcia, E, Lopez-Casas, P P, Megias, D, Guerra, C, Muñoz, M, Quijano, Y, Cubillo, A, Rodriguez-Pascual, J, Plaza, C, de Vicente, E, Prados, S, Tabernero, S, Barbacid, M, Lopez-Rios, F, Hidalgo, MEnlace del recurso
Publicado 2014
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1638por Ramírez, N, Viúdez, A, Hernández-García, I, Guerrero, D, Gómez-Dorronsoro, M, Herrera, F J, Vila, J, Beloki, L, Ciaúrriz, M, Mansilla, C, Vera, REnlace del recurso
Publicado 2014
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1639“…Pdx-1-cre LSL/KrasG12D/Ink4a/Arf null B6 mice always develop pancreatic cancer, allowing only 30% survival by 8 weeks, while each of the Mirk kinase inhibitor treated mice survived 8 weeks. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1640por Kang, R, Hou, W, Zhang, Q, Chen, R, Lee, Y J, Bartlett, D L, Lotze, M T, Tang, D, Zeh, H J“…A hypoxic tumor microenvironment is characteristic of many cancer types, including one of the most lethal, pancreatic cancer. We recently demonstrated that the receptor for advanced glycation end products (RAGE) has an important role in promoting the development of pancreatic cancer and attenuating the response to chemotherapy. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto